KaydedilenlerDerginizi ekleyin

Dergiler / Medicine Science / 2021 / Cilt: 10 - Sayı: 4

The efficacy of Pharmacomechanical catheter-directed thrombolysis in patients with concomitant deep vein thrombosis and pulmonary embolism: A retrospective analysis of 26 patients

Emced Khalil
Sayfa
1452–1456
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

A significant improvement in SaO2 was observed following the infusion of urokinase compared to baseline values (94.5±1.1 % vs. 98.6±0.5 %, p

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:This study aimed to analyze the impact of pharmacomechanical catheter-directed thrombolysis (PCDT) on venous patency, pulmonary artery systolic pressure, O2 saturation and in-hospital mortality in patients admitted for deep vein thrombosis (DVT) and concomitant pulmonary embolism (PE).
📊
Temel Bulgular & Veri:The primary end-point of this study was the difference in pre-and post PCDT sPAP and O2 saturation.
💡
Sonuç & Katkı:A significant improvement in SaO2 was observed following the infusion of urokinase compared to baseline values (94.5±1.1 % vs. 98.6±0.5 %, p
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

This study aimed to analyze the impact of pharmacomechanical catheter-directed thrombolysis (PCDT) on venous patency, pulmonary artery systolic pressure, O2 saturation and in-hospital mortality in patients admitted for deep vein thrombosis (DVT) and concomitant pulmonary embolism (PE). Twenty-six patients presenting with DVT and concomitant non-massive PE were analyzed in aretrospective manner. All subjects underwent PCDT with urokinase. The primary end-point of this study was the difference in pre-and post PCDT sPAP and O2 saturation. Duplex ultrasonography performed before discharge revealed complete recanalization of the compromised vein in 21 (80%) of the subjects. Duplex ultrasonography performed 3 months after discharge showed restenosis of the compromised vein in only two patients (8%). There was partial recanalization in 5 patients (20%). A significant improvement in SaO2 was observed following the infusion of urokinase compared to baseline values (94.5±1.1 % vs. 98.6±0.5 %, p

🔖

Bu Makaleye Atıf Yap

Khalil, E. (2022). The efficacy of Pharmacomechanical catheter-directed thrombolysis in patients with concomitant deep vein thrombosis and pulmonary embolism: A retrospective analysis of 26 patients. Medicine Science, Cilt: 10 - Sayı: 4, 1452–1456. https://ajindex.com/articles/579750

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Giordano NJ, Jansson PS, Young MN, et al. Epidemiology, Pathophysiology, Stratification, and Natural History of Pulmonary Embolism. Tech Vasc Interv Radiol. 2017;20:135-40
  2. Anderson Jr FA, Zayaruzny M, Heit JA, et al. Estimated annual numbers of US acute‐care hospital patients at risk for venous thromboembolism. Am J Hematol. 2007;82:777-82
  3. Smith SB, Geske JB, Kathuria P, et al. Analysis of national trends in admissions for pulmonary embolism. Chest. 2016;150:35-45
  4. Crous-Bou M, Harrington LB, Kabrhel C. Environmental and Genetic Risk Factors Associated with Venous Thromboembolism. Semin Thromb Hemost. 2016;42:808-20
  5. Tritschler T, Kraaijpoel N, Le Gal G, et al. Venous thromboembolism: advances in diagnosis and treatment. JAMA. 2018;320:1583-94
  6. Comerota AJ, Grewal N, Martinez JT, et al. Postthrombotic morbidity for iliofemoral deep vein thrombosis. J Vasc Surg. 2012;55:768-73
  7. Baekgaard N, Broholm R, Just S, Jet al. Long-term results using catheterdirected thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg. 2010;39:112-7
  8. Schulman S, Ageno W, Konstantinides SV. Venous thromboembolism: Past, present and future. Thromb Haemost. 2017;117:1219-29
  9. Battinelli EM, Murphy DL, Connors JM. Venous thromboembolism overview. Hematol Oncol Clin North Am. 2012;26:345-67, ix
  10. Beckman MG, Hooper WC, Critchley SE, et al. Venous thromboembolism: a public health concern. Am J Prev Med. 2010;38:S495-501
  11. Forster A, Wells P. Tissue plasminogen activator for the treatment of deep venous thrombosis of the lower extremity: a systematic review. Chest. 2001;119:572-9
  12. Turpie AG, Levine MN, Hirsh J, et al. Tissue plasminogen activator (rt-PA) vs heparin in deep vein thrombosis. Results of a randomized trial. Chest. 1990;97:172-5
  13. Miller DJ, Simpson JR, Silver B. Safety of thrombolysis in acute ischemic stroke: a review of complications, risk factors, and newer technologies. Neurohospitalist. 2011;1:138-47
  14. Chiarello MA, Sista AK. Catheter-Directed Thrombolysis for Submassive Pulmonary Embolism. Semin Intervent Radiol. 2018;35:122-8
  15. Güneş Y, Sincer I, Erdal E. Catheter-directed intra-arterial thrombolysis for lower extremity arterial occlusions. Anatol J Cardiol. 2019;22:54-9
  16. Avgerinos ED, Saadeddin Z, Abou Ali AN, et al. A meta-analysis of outcomes of catheter-directed thrombolysis for high- and intermediate-risk pulmonary embolism. J Vasc Surg Venous Lymphat Disord. 2018;6:530